This is a lung disease caused by breathing in a rare metal called beryllium. It can happen in people who work with beryllium, like in certain industries. It causes inflammation in the lungs, making it hard to breathe.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Berylliosis?
Berylliosis, more often called chronic beryllium disease, is a long-term lung disease caused by the body's immune reaction to beryllium, a lightweight metal used in many industries. In people who react to it, inhaled beryllium particles set off persistent inflammation that forms small clusters of immune cells in the lungs, called granulomas. Over time this inflammation can stiffen and scar the lungs, making it harder to breathe and to get enough oxygen. Common symptoms include shortness of breath, especially with exertion, a lingering dry cough, tiredness, weight loss, fevers and night sweats. Some people have no symptoms at all when the disease is first found through workplace screening. The disease is closely related to beryllium sensitization, an immune response to beryllium that shows up on a blood test but has not yet caused lung disease. Sensitization is not an illness in itself, but it means a person can develop chronic beryllium disease. A separate condition, acute beryllium disease, is a sudden chemical pneumonia from very heavy exposure; it is now extremely rare in workplaces.
Chronic beryllium disease only develops after exposure to beryllium, almost always at work. Beryllium is used in aerospace, defense, electronics, energy, metal alloys and dental work, and it can also be present in metals that workers do not realize contain it. Breathing in dust or fumes is the main route, but skin contact can also trigger sensitization. Because the disease is an immune reaction rather than ordinary poisoning, it does not depend only on how much beryllium someone breathed in. Only a minority of exposed workers become sensitized and go on to develop disease, and it can occur even at exposures below current legal limits. Higher exposure raises the chance, and so does a common inherited variation in an immune gene (HLA-DPB1), though carrying it does not mean disease is certain. Symptoms can begin months or many years after exposure, sometimes long after a person has left the job. Family members can be exposed through dust carried home on clothing, which is why workers are advised to shower or change before leaving work.
Diagnosis rests on three things: a history of beryllium exposure, proof that the immune system reacts to beryllium, and signs of the characteristic inflammation in the lungs. Because many people do not know they were exposed, a detailed job history is often the key step. The main test is the beryllium lymphocyte proliferation test (BeLPT). It is a blood test that checks whether white blood cells multiply when they meet beryllium in the lab. An abnormal result is usually repeated to confirm it, because a single test can be wrong, and a negative test does not completely rule the disease out. Tests that measure beryllium levels in blood or urine only reflect recent exposure and cannot diagnose the disease. A person with confirmed sensitization is then checked for lung involvement with breathing tests (pulmonary function tests), a chest CT scan and often bronchoscopy, in which a thin camera tube is passed into the airways to wash out cells and take small tissue samples. Granulomas in the lung plus sensitization confirm chronic beryllium disease. Chronic beryllium disease looks almost identical to sarcoidosis, another granuloma-forming lung disease, on scans and under the microscope. Some people are treated for sarcoidosis for years before beryllium is recognized, so anyone with sarcoidosis and a history of metalwork or similar jobs may reasonably ask about BeLPT testing.
There is no cure for chronic beryllium disease, but treatment can calm the inflammation, protect lung function and ease symptoms. Most of the evidence comes from clinical experience and observational studies rather than controlled trials. The first step is ending further exposure to beryllium. Specialists strongly recommend this for people with the disease, and some people improve after leaving exposure, though others continue to progress. In the United States, workers covered by the beryllium standard of the Occupational Safety and Health Administration (OSHA) who are sensitized or diagnosed can request removal from exposure and referral to a specialized center. People with early disease and normal lung function are often monitored rather than treated right away. When breathing tests show significant abnormality or decline, the usual treatment is an oral corticosteroid such as prednisone, which suppresses the immune reaction. It is typically taken for months and then tapered to the lowest dose that keeps the disease under control. Long-term steroid use carries meaningful side effects, such as weight gain, raised blood sugar, bone thinning and infection risk, so some people take a steroid-sparing medicine such as methotrexate or azathioprine (immune-suppressing drugs also used for sarcoidosis) to allow a lower steroid dose. Treatment can slow or partly reverse inflammation, but it cannot undo scarring that has already formed, which is why earlier treatment of progressive disease matters. Supportive care includes oxygen when blood oxygen levels are low, pulmonary rehabilitation to maintain strength and stamina, and vaccines against influenza and pneumococcal pneumonia.
The course varies widely. Many people found through workplace screening have mild disease that stays stable for years, and sensitization alone does not appear to shorten life. Others develop slowly worsening breathlessness, and in more advanced cases scarring can lead to low oxygen levels, strain on the right side of the heart and respiratory failure. Overall, people with chronic beryllium disease have a higher risk of dying from lung disease than the general population. Living with the disease usually means regular follow-up rather than a single course of treatment. People with sensitization or early disease are typically re-checked every year or two with breathing tests and sometimes imaging, so that progression can be caught and treated. People taking steroids need monitoring for side effects as well as for how well the lungs respond. The diagnosis can affect work, since staying away from beryllium often means changing jobs or duties. Because it is an occupational disease, coworkers may also benefit from screening, and some people qualify for workplace protections or compensation programs.
Arrange a medical evaluation if you have worked with beryllium or beryllium-containing metals, now or in the past, and develop shortness of breath, a cough that will not go away, unexplained weight loss, fevers or night sweats. Tell the clinician about the exposure, since it changes which tests are needed. Ask about BeLPT screening if you have been exposed, even without symptoms. If you already have the disease, contact your care team promptly if your breathing gets noticeably worse, you can do less than usual, or you develop new swelling in your legs, which can signal strain on the heart. People on steroids or other immune-suppressing medicines should also call their care team about fever or signs of infection.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Berylliosis is like, what's helped you, or ask the community a question.